Nirvana Life Sciences Inc.NIRV-X.CN

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · CSE · Canada · nirvanalifescience.com

Nirvana Life Sciences Inc. develops non-addictive pain treatments and addiction therapies derived from psychedelic compounds. Its shares trade on the CSE non-compliant tier and were subject to a cease trade order in September 2026.

Key ratios

ROA

-1018.4%TTM

2025 -1059.3%2024 -1001.1%2023 -264.7%

Recent news

Canadian Investment Regulatory Organization Trading Halt - NIRV.X 2026-09-04 · CNW

Track NIRV-X.CN in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer